• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,470.11 -238.41
( -0.31%)
Global Indices
Nasdaq
51,860.73 -306.69
(-0.59%)
Dow Jones
7,464.20 -14.49
(-0.19%)
Hang Seng
66,064.76 1,923.64
(3.00%)
Nikkei 225
10,580.59 55.83
(0.53%)
Forex
USD-INR
96.42 0.06
(0.07%)
EUR-INR
110.27 -0.10
(-0.09%)
GBP-INR
129.65 -0.46
(-0.35%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Avience Biomedicals Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
94324
INE0V9I01017
157.0914426
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AVIENCE
21.32
143.63
EPS(TTM)
Face Value()
Div & Yield %
12.28
10
0
 

ksb ltd
KNR Constructions consolidated net profit declines 23.72% in the March 2026 quarter
May 30,2026
Net profit of KNR Constructions declined 23.72% to Rs 106.21 crore in the quarter ended March 2026 as against Rs 139.24 crore during the previous quarter ended March 2025. Sales declined 28.67% to Rs 695.59 crore in the quarter ended March 2026 as against Rs 975.21 crore during the previous quarter ended March 2025.

For the full year,net profit declined 56.37% to Rs 437.08 crore in the year ended March 2026 as against Rs 1001.87 crore during the previous year ended March 2025. Sales declined 43.24% to Rs 2698.01 crore in the year ended March 2026 as against Rs 4753.17 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales695.59975.21 -29 2698.014753.17 -43
OPM %24.3122.71 -26.3734.20 -
PBDT132.29206.21 -36 564.841733.17 -67
PBT118.34183.36 -35 505.381418.95 -64
NP106.21139.24 -24 437.081001.87 -56